{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T22:54:35Z","timestamp":1783551275418,"version":"3.55.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["62072377"],"award-info":[{"award-number":["62072377"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10822-025-00735-9","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T07:44:54Z","timestamp":1768203894000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["AI-driven peptide discovery for endometrial cancer: deep generative modeling and molecular simulation in the big data era"],"prefix":"10.1007","volume":"40","author":[{"given":"Israr","family":"Fatima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdur","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafeez","family":"Ur Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Aldaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawood Ahmed","family":"Warraich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhi","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"issue":"10333","key":"735_CR1","first-page":"1412","volume":"399","author":"EJ Crosbie","year":"2022","unstructured":"Crosbie EJ et al (2022) Endometrial cancer 399(10333):1412\u20131428","journal-title":"Endometrial cancer"},{"issue":"5","key":"735_CR2","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.3390\/biomedicines10051190","volume":"10","author":"S Januszyk","year":"2022","unstructured":"Januszyk S et al (2022) Expression profile of mRNAs and miRNAs related to the oxidative-stress phenomenon in the ishikawa cell line treated either cisplatin or salinomycin. Biomedicines 10(5):1190","journal-title":"Biomedicines"},{"issue":"12","key":"735_CR3","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1017\/S0007114522002872","volume":"129","author":"G Esposito","year":"2023","unstructured":"Esposito G et al (2023) Adherence to the World Cancer Research Fund\/American Institute for Cancer Research recommendations and endometrial cancer risk: a multicentric case\u2013control study. Br J Nutr 129(12):2133\u20132141","journal-title":"Br J Nutr"},{"key":"735_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2024.101494","volume":"55","author":"KB Shelvin","year":"2024","unstructured":"Shelvin KB et al (2024) Recurrent high grade serous endometrial cancer with brain metastases: immunotherapy confers improved quality of life and survival. Gynecol Oncol Rep 55:101494","journal-title":"Gynecol Oncol Rep"},{"key":"735_CR5","doi-asserted-by":"publisher","DOI":"10.1177\/20552076231181201","volume":"9","author":"K Churruca","year":"2023","unstructured":"Churruca K et al (2023) The place of digital triage in a complex healthcare system: an interview study with key stakeholders in Australia\u2019s national provider. DIGITAL HEALTH 9:20552076231181201","journal-title":"DIGITAL HEALTH"},{"key":"735_CR6","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1200\/PO.21.00249","volume":"5","author":"MD Levine","year":"2021","unstructured":"Levine MD et al (2021) Up-front multigene panel testing for cancer susceptibility in patients with newly diagnosed endometrial cancer: a multicenter prospective study. JCO Precis Oncol 5:1588\u20131602","journal-title":"JCO Precis Oncol"},{"issue":"23","key":"735_CR7","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1056\/NEJMoa2302312","volume":"388","author":"RN Eskander","year":"2023","unstructured":"Eskander RN et al (2023) Pembrolizumab plus chemotherapy in advanced endometrial cancer. New Engl J Med 388(23):2159\u20132170","journal-title":"New Engl J Med"},{"issue":"2","key":"735_CR8","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/ijgo.14923","volume":"162","author":"JS Berek","year":"2023","unstructured":"Berek JS et al (2023) FIGO staging of endometrial cancer: 2023. Int J Gynaecol Obstet 162(2):383\u2013394","journal-title":"Int J Gynaecol Obstet"},{"issue":"13","key":"735_CR9","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1200\/JCO.20.03399","volume":"39","author":"LA Korde","year":"2021","unstructured":"Korde LA et al (2021) Neoadjuvant chemotherapy, endocrine therapy, and targeted therapy for breast cancer: ASCO guideline. J Clin Oncol 39(13):1485\u20131505","journal-title":"J Clin Oncol"},{"issue":"24","key":"735_CR10","doi-asserted-by":"publisher","first-page":"6275","DOI":"10.3390\/cancers13246275","volume":"13","author":"H R\u00fctten","year":"2021","unstructured":"R\u00fctten H et al (2021) Recurrent endometrial cancer: local and systemic treatment options. Cancers 13(24):6275","journal-title":"Cancers"},{"issue":"17","key":"735_CR11","first-page":"4176","volume":"14","author":"S Restaino","year":"2022","unstructured":"Restaino S et al (2022) Recurrent endometrial cancer: Which is the best treatment? Syst Rev Lit 14(17):4176","journal-title":"Syst Rev Lit"},{"key":"735_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00733","volume":"11","author":"W Cui","year":"2020","unstructured":"Cui W et al (2020) Discovering anti-cancer drugs via computational methods. Front Pharmacol 11:733","journal-title":"Front Pharmacol"},{"issue":"3","key":"735_CR13","first-page":"149","volume":"9","author":"R Kumar","year":"2022","unstructured":"Kumar R, Saha P (2022) A review on artificial intelligence and machine learning to improve cancer management and drug discovery. Int J Res Appl Sci Biotechnol 9(3):149\u2013156","journal-title":"Int J Res Appl Sci Biotechnol"},{"issue":"9","key":"735_CR14","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1080\/17460441.2021.1883585","volume":"16","author":"Z Tanoli","year":"2021","unstructured":"Tanoli Z, V\u00e4h\u00e4-Koskela M, Aittokallio TJEoodd (2021) Artificial intelligence, machine learning, and drug repurposing in cancer. Expert Opin Drug Discov 16(9):977\u2013989","journal-title":"Expert Opin Drug Discov"},{"key":"735_CR15","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/j.csbj.2023.02.004","volume":"21","author":"X Pan","year":"2023","unstructured":"Pan X et al (2023) AI-DrugNet: a network-based deep learning model for drug repurposing and combination therapy in neurological disorders. Comput Struct Biotechnol J 21:1533\u20131542","journal-title":"Comput Struct Biotechnol J"},{"key":"735_CR16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.neunet.2022.03.037","volume":"152","author":"Y Matsuo","year":"2022","unstructured":"Matsuo Y et al (2022) Deep learning, reinforcement learning, and world models. Neural Netw 152:267\u2013275","journal-title":"Neural Netw"},{"issue":"14","key":"735_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25143250","volume":"25","author":"E Lin","year":"2020","unstructured":"Lin E, Lin C-H, Lane H-YJM (2020) Relevant applications of generative adversarial networks in drug design and discovery: molecular de novo design, dimensionality reduction, and de novo peptide and protein design. Molecules 25(14):3250","journal-title":"Molecules"},{"issue":"30","key":"735_CR18","doi-asserted-by":"publisher","first-page":"25958","DOI":"10.1021\/acsomega.2c03264","volume":"7","author":"D Menon","year":"2022","unstructured":"Menon D, Ranganathan RJAo (2022) A generative approach to materials discovery, design, and optimization. ACS Omega 7(30):25958\u201325973","journal-title":"ACS Omega"},{"key":"735_CR19","unstructured":"Nguyen, H., (2024) De novo molecular design using deep learning. Open Access Te Herenga Waka-Victoria University of Wellington."},{"key":"735_CR20","doi-asserted-by":"crossref","unstructured":"Mak K.-K, et al., (2024) Artificial intelligence in drug discovery and development. pp 1461\u20131498","DOI":"10.1007\/978-3-031-35529-5_92"},{"issue":"4","key":"735_CR21","first-page":"100179","volume":"2","author":"Y Xu","year":"2021","unstructured":"Xu Y et al (2021) Artificial intelligence: a powerful paradigm for scientific research. Innovation 2(4):100179","journal-title":"Innovation"},{"issue":"17","key":"735_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/app11177772","volume":"11","author":"D Zhuang","year":"2021","unstructured":"Zhuang D, Ibrahim AKJAS (2021) Deep learning for drug discovery: a study of identifying high efficacy drug compounds using a cascade transfer learning approach. Appl Sci 11(17):7772","journal-title":"Appl Sci"},{"issue":"6","key":"735_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ph16060891","volume":"16","author":"A Blanco-Gonzalez","year":"2023","unstructured":"Blanco-Gonzalez A et al (2023) The role of AI in drug discovery: challenges, opportunities, and strategies. Pharmaceuticals 16(6):891","journal-title":"Pharmaceuticals"},{"issue":"16","key":"735_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13163949","volume":"13","author":"F Rascio","year":"2021","unstructured":"Rascio F et al (2021) The pathogenic role of PI3K\/AKT pathway in cancer onset and drug resistance: an updated review. Cancers 13(16):3949","journal-title":"Cancers"},{"key":"735_CR25","doi-asserted-by":"crossref","unstructured":"Ledinek, \u017d., M. Sobo\u010dan, and J.J.D.M. Knez, The role of CTNNB1 in endometrial cancer. 2022. 2022(1): p. 1442441.","DOI":"10.1155\/2022\/1442441"},{"issue":"19","key":"735_CR26","doi-asserted-by":"publisher","first-page":"4689","DOI":"10.3390\/cancers15194689","volume":"15","author":"P Miziak","year":"2023","unstructured":"Miziak P et al (2023) Estrogen receptor signaling in breast cancer. Cancer 15(19):4689","journal-title":"Cancer"},{"issue":"5","key":"735_CR27","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1056\/NEJMoa2108330","volume":"386","author":"V Makker","year":"2022","unstructured":"Makker V et al (2022) Lenvatinib plus pembrolizumab for advanced endometrial cancer. N Engl J Med 386(5):437\u2013448","journal-title":"N Engl J Med"},{"issue":"07","key":"735_CR28","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1142\/S0192415X22500847","volume":"50","author":"W Huang","year":"2022","unstructured":"Huang W et al (2022) Arteannuin B enhances the effectiveness of cisplatin in non-small cell lung cancer by regulating connexin 43 and MAPK pathway. Am J Chin Med 50(07):1963\u20131992","journal-title":"Am J Chin Med"},{"key":"735_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1013463","volume":"13","author":"\u017d Ledinek","year":"2023","unstructured":"Ledinek \u017d et al (2023) The association of Wnt-signalling and EMT markers with clinical characteristics in women with endometrial cancer. Front Oncol 13:1013463","journal-title":"Front Oncol"},{"issue":"5","key":"735_CR30","first-page":"52","volume":"2","author":"D Kanahaiya","year":"2017","unstructured":"Kanahaiya D, Senthilraja P, Manivel G (2017) In silico analysis on phytoestrogens from dried fruits as beta-catenin inhibitors in liver cancer. Res J Life Sci Bioinform Pharm Chem Sci 2(5):52","journal-title":"Res J Life Sci Bioinform Pharm Chem Sci"},{"issue":"6","key":"735_CR31","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1109\/MSP.2017.2743240","volume":"34","author":"K Arulkumaran","year":"2017","unstructured":"Arulkumaran K et al (2017) Deep reinforcement learning: a brief survey. IEEE Signal Process Mag 34(6):26\u201338","journal-title":"IEEE Signal Process Mag"},{"issue":"1","key":"735_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34692-w","volume":"13","author":"Y Li","year":"2022","unstructured":"Li Y et al (2022) Generative deep learning enables the discovery of a potent and selective RIPK1 inhibitor. Nat Commun 13(1):6891","journal-title":"Nat Commun"},{"issue":"11","key":"735_CR33","doi-asserted-by":"publisher","first-page":"5343","DOI":"10.1021\/acs.jcim.0c01496","volume":"61","author":"T Sousa","year":"2021","unstructured":"Sousa T et al (2021) Generative deep learning for targeted compound design. J Chem Inf Model 61(11):5343\u20135361","journal-title":"J Chem Inf Model"},{"issue":"3","key":"735_CR34","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1007\/s10462-021-10058-4","volume":"55","author":"S Dara","year":"2022","unstructured":"Dara S et al (2022) Machine learning in drug discovery: a review. Artif Intell Rev 55(3):1947\u20131999","journal-title":"Artif Intell Rev"},{"issue":"11","key":"735_CR35","doi-asserted-by":"publisher","first-page":"7210","DOI":"10.1021\/acs.jmedchem.1c00416","volume":"64","author":"PD Leeson","year":"2021","unstructured":"Leeson PD et al (2021) Target-based evaluation of \u201cdrug-like\u201d properties and ligand efficiencies. J Med Chem 64(11):7210\u20137230","journal-title":"J Med Chem"},{"issue":"2","key":"735_CR36","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/17460441.2016.1272757","volume":"12","author":"H Yao","year":"2017","unstructured":"Yao H et al (2017) The structural modification of natural products for novel drug discovery. Expert Opin Drug Discov 12(2):121\u2013140","journal-title":"Expert Opin Drug Discov"},{"issue":"8","key":"735_CR37","doi-asserted-by":"publisher","first-page":"4573","DOI":"10.1128\/AAC.02463-14","volume":"58","author":"PS Ocampo","year":"2014","unstructured":"Ocampo PS et al (2014) Antagonism between bacteriostatic and bactericidal antibiotics is prevalent. Antimicrob Agents Chemother 58(8):4573\u20134582","journal-title":"Antimicrob Agents Chemother"},{"key":"735_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/9781394268832.ch22","author":"AG Amkamgari","year":"2025","unstructured":"Amkamgari AG et al (2025) PacMan-RL: a game-changing approach to drug development through reinforcement learning. Genomics Nexus Comput Vision Mach Learning. https:\/\/doi.org\/10.1002\/9781394268832.ch22","journal-title":"Genomics Nexus Comput Vision Mach Learning"},{"key":"735_CR39","unstructured":"Su\u00e1rez-Varela Maci\u00e0, J.R., Enabling knowledge-defined networks: deep reinforcement learning, graph neural networks and network analytics. 2020."},{"issue":"1","key":"735_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-023-00725-9","volume":"15","author":"UV Ucak","year":"2023","unstructured":"Ucak UV, Ashyrmamatov I, Lee JJJoc (2023) Improving the quality of chemical language model outcomes with atom-in-SMILES tokenization. J Cheminform 15(1):55","journal-title":"J Cheminform"},{"key":"735_CR41","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1093\/nar\/gkr777","volume":"40","author":"A Gaulton","year":"2012","unstructured":"Gaulton A et al (2012) ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res 40:1100\u201341107","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"735_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23105727","volume":"23","author":"S Kralj","year":"2022","unstructured":"Kralj S, Juki\u010d M, Bren UJIJoMS (2022) Comparative analyses of medicinal chemistry and cheminformatics filters with accessible implementation in Konstanz information miner (KNIME). Int J Mol Sci 23(10):5727","journal-title":"Int J Mol Sci"},{"issue":"3","key":"735_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.202401349","volume":"22","author":"TT Odunitan","year":"2025","unstructured":"Odunitan TT et al (2025) Beyond conventional drug design: exploring the broad\u2010spectrum efficacy of antimicrobial peptides. Chem Biodivers 22(3):e202401349","journal-title":"Chem Biodivers"},{"issue":"D1","key":"735_CR44","doi-asserted-by":"publisher","first-page":"D439","DOI":"10.1093\/nar\/gkab1061","volume":"50","author":"M Varadi","year":"2022","unstructured":"Varadi M et al (2022) AlphaFold protein structure database: massively expanding the structural coverage of protein-sequence space with high-accuracy models. Nucleic Acids Res 50(D1):D439\u2013D444","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"735_CR45","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1093\/nar\/gkaa977","volume":"49","author":"M Blum","year":"2021","unstructured":"Blum M et al (2021) The InterPro protein families and domains database: 20 years on. Nucleic Acids Res 49(1):344\u2013354","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"735_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-025-00973-x","volume":"17","author":"AT McNutt","year":"2025","unstructured":"McNutt AT et al (2025) GNINA 1.3: the next increment in molecular docking with deep learning. J Cheminform 17(1):28","journal-title":"J Cheminform"},{"key":"735_CR47","first-page":"2019","volume":"2019","author":"Release, S., 1: Desmond Molecular Dynamics System, DE Shaw Research, New York, NY","year":"2019","unstructured":"Release, S., 1: Desmond Molecular Dynamics System, DE Shaw Research, New York, NY (2019) Maestro-Desmond Interoperability Tools. Schr\u00f6dinger, New York, NY 2019:2019","journal-title":"Schr\u00f6dinger, New York, NY"},{"issue":"1","key":"735_CR48","doi-asserted-by":"publisher","first-page":"6387","DOI":"10.1038\/ncomms7387","volume":"6","author":"VR Krishnamurthy","year":"2015","unstructured":"Krishnamurthy VR et al (2015) Glycopeptide analogues of PSGL-1 inhibit P-selectin in vitro and in vivo. Nat Commun 6(1):6387","journal-title":"Nat Commun"},{"issue":"6","key":"735_CR49","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/bioinformatics\/bty707","volume":"35","author":"H Yang","year":"2019","unstructured":"Yang H et al (2019) admetSAR 2.0: web-service for prediction and optimization of chemical ADMET properties. Bioinformatics 35(6):1067\u20131069","journal-title":"Bioinformatics"},{"key":"735_CR50","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/B978-0-323-91172-6.00012-1","volume-title":"Computational approaches for novel therapeutic and diagnostic designing to mitigate SARS-CoV-2 infection","author":"P Sucharitha","year":"2022","unstructured":"Sucharitha P et al (2022) Absorption, distribution, metabolism, excretion, and toxicity assessment of drugs using computational tools. Computational approaches for novel therapeutic and diagnostic designing to mitigate SARS-CoV-2 infection. Elsevier, pp 335\u2013355"},{"key":"735_CR51","doi-asserted-by":"crossref","unstructured":"Cheng, F., et al., (2012) admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties. ACS Publications","DOI":"10.1021\/ci300367a"},{"issue":"12","key":"735_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26123625","volume":"26","author":"H Hajlaoui","year":"2021","unstructured":"Hajlaoui H et al (2021) Antimicrobial, antioxidant, anti-acetylcholinesterase, antidiabetic, and pharmacokinetic properties of Carum carvi L. and Coriandrum sativum L. essential oils alone and in combination. Molecules 26(12):3625","journal-title":"Molecules"},{"issue":"4","key":"735_CR53","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1021\/acs.jctc.7b00028","volume":"13","author":"K Sargsyan","year":"2017","unstructured":"Sargsyan K et al (2017) How molecular size impacts RMSD applications in molecular dynamics simulations. J Chem Theory Comput 13(4):1518\u20131524","journal-title":"J Chem Theory Comput"},{"key":"735_CR54","doi-asserted-by":"publisher","DOI":"10.46602\/jcsn.v48i1.856","author":"O Yusuff","year":"2023","unstructured":"Yusuff O, Omotosho K, Raji A (2023) Comparative chains dynamics of triosephosphate isomerase investigated by molecular dynamics simulation. J Chem Soc Niger. https:\/\/doi.org\/10.46602\/jcsn.v48i1.856","journal-title":"J Chem Soc Niger"},{"issue":"7","key":"735_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/w12071969","volume":"12","author":"Y Zhao","year":"2020","unstructured":"Zhao Y et al (2020) Analysis of the evolution of drought, flood, and drought-flood abrupt alternation events under climate change using the daily SWAP index. Water 12(7):1969","journal-title":"Water"},{"issue":"3","key":"735_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgc.2025.101671","volume":"35","author":"A Bergamini","year":"2025","unstructured":"Bergamini A et al (2025) Controversies in the management of grade 1 and 2 endometrioid carcinoma of the ovary and uterus. Int J Gynecol Cancer 35(3):101671","journal-title":"Int J Gynecol Cancer"},{"issue":"8","key":"735_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19082348","volume":"19","author":"T Van Nyen","year":"2018","unstructured":"Van Nyen T et al (2018) Modeling endometrial cancer: past, present, and future. Int J Mol Sci 19(8):2348","journal-title":"Int J Mol Sci"},{"issue":"44","key":"735_CR58","doi-asserted-by":"publisher","first-page":"77121","DOI":"10.18632\/oncotarget.20365","volume":"8","author":"B Manavalan","year":"2017","unstructured":"Manavalan B et al (2017) MLACP: machine-learning-based prediction of anticancer peptides. Oncotarget 8(44):77121","journal-title":"Oncotarget"},{"key":"735_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e10608","author":"R Ranasinghe","year":"2022","unstructured":"Ranasinghe R, Mathai ML, Zulli AJH (2022) Cisplatin for cancer therapy and overcoming chemoresistance. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e10608","journal-title":"Heliyon"},{"key":"735_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.engappai.2022.104751","volume":"110","author":"WJEAoAI Serrano","year":"2022","unstructured":"Serrano WJEAoAI (2022) Deep reinforcement learning with the random neural network. Eng Appl Artif Intell 110:104751","journal-title":"Eng Appl Artif Intell"},{"key":"735_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.is.2021.101878","volume":"104","author":"T Li","year":"2022","unstructured":"Li T et al (2022) Electronic health records based reinforcement learning for treatment optimizing. Inf Syst 104:101878","journal-title":"Inf Syst"},{"issue":"8","key":"735_CR62","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1080\/17460441.2022.2072288","volume":"17","author":"RK Tan","year":"2022","unstructured":"Tan RK, Liu Y, Xie LJEoodd (2022) Reinforcement learning for systems pharmacology-oriented and personalized drug design. Expert Opin Drug Discov 17(8):849\u2013863","journal-title":"Expert Opin Drug Discov"},{"key":"735_CR63","first-page":"1","volume":"57","author":"L Lai","year":"2025","unstructured":"Lai L et al (2025) Deep generative models for therapeutic peptide discovery: a comprehensive review. ACM Comput Surv 57:1","journal-title":"ACM Comput Surv"},{"issue":"1","key":"735_CR64","first-page":"655","volume":"15","author":"BL Moore","year":"2014","unstructured":"Moore BL et al (2014) Reinforcement learning for closed-loop propofol anesthesia: a study in human volunteers. J Mach Learning Res 15(1):655\u2013696","journal-title":"J Mach Learning Res"},{"issue":"6","key":"735_CR65","doi-asserted-by":"publisher","first-page":"9737","DOI":"10.1016\/j.eswa.2009.02.041","volume":"36","author":"JD Mart\u00edn-Guerrero","year":"2009","unstructured":"Mart\u00edn-Guerrero JD et al (2009) A reinforcement learning approach for individualizing erythropoietin dosages in hemodialysis patients. Expert Syst Appl 36(6):9737\u20139742","journal-title":"Expert Syst Appl"},{"key":"735_CR66","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.mbs.2017.08.004","volume":"293","author":"R Padmanabhan","year":"2017","unstructured":"Padmanabhan R, Meskin N, Haddad WMJMb (2017) Reinforcement learning-based control of drug dosing for cancer chemotherapy treatment. Math Biosci 293:11\u201320","journal-title":"Math Biosci"},{"key":"735_CR67","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cmpb.2019.03.004","volume":"173","author":"P Yazdjerdi","year":"2019","unstructured":"Yazdjerdi P et al (2019) Reinforcement learning-based control of tumor growth under anti-angiogenic therapy. Comput Methods Programs Biomed 173:15\u201326","journal-title":"Comput Methods Programs Biomed"},{"key":"735_CR68","unstructured":"Lillicrap TP, et al., (2015) Continuous control with deep reinforcement learning."},{"issue":"4","key":"735_CR69","doi-asserted-by":"publisher","first-page":"908","DOI":"10.3390\/biomedinformatics3040056","volume":"3","author":"F Fu","year":"2023","unstructured":"Fu F et al (2023) Identifying the role of disulfidptosis in endometrial cancer via machine learning methods. BioMedInformatics 3(4):908\u2013925","journal-title":"BioMedInformatics"},{"key":"735_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.artmed.2021.102137","volume":"119","author":"M Tortora","year":"2021","unstructured":"Tortora M et al (2021) Deep reinforcement learning for fractionated radiotherapy in non-small cell lung carcinoma. Artif Intell Med 119:102137","journal-title":"Artif Intell Med"},{"key":"735_CR71","doi-asserted-by":"publisher","first-page":"4944","DOI":"10.1016\/j.csbj.2023.10.025","volume":"21","author":"T Wang","year":"2023","unstructured":"Wang T et al (2023) Development and validation of a novel DNA damage repair-related long non-coding RNA signature in predicting prognosis, immunity, and drug sensitivity in uterine corpus endometrial carcinoma. Comput Struct Biotechnol J 21:4944\u20134959","journal-title":"Comput Struct Biotechnol J"},{"issue":"1","key":"735_CR72","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2174\/156802610790232233","volume":"10","author":"A Sarkar","year":"2010","unstructured":"Sarkar A, Kellogg GEJC (2010) Hydrophobicity-shake flasks, protein folding and drug discovery. Curr Top Med Chem 10(1):67\u201383","journal-title":"Curr Top Med Chem"},{"issue":"5","key":"735_CR73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0217031","volume":"14","author":"F Tavakoli","year":"2019","unstructured":"Tavakoli F, Ganjalikhany MRJPo (2019) Structure-based inhibitory peptide design targeting peptide-substrate binding site in EGFR tyrosine kinase. PLoS ONE 14(5):e0217031","journal-title":"PLoS ONE"},{"issue":"16","key":"735_CR74","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241612931","volume":"24","author":"NTT Nh\u00e0n","year":"2023","unstructured":"Nh\u00e0n NTT, Yamada T, Yamada KH (2023) Peptide-based agents for cancer treatment: current applications and future directions. Int J Mol Sci 24(16):12931","journal-title":"Int J Mol Sci"},{"key":"735_CR75","unstructured":"Adhikari, C., Unlocking the Future of Pharmaceuticals: AI Techniques in Drug Discovery."},{"key":"735_CR76","doi-asserted-by":"crossref","unstructured":"Fang, H., et al. (2024) Deep reinforcement learning with driving intention for on-ramp decision-making. In: International Conference on Autonomous Unmanned Systems. Springer.","DOI":"10.1007\/978-981-96-3560-3_5"},{"issue":"4","key":"735_CR77","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btad157","volume":"39","author":"Y Fang","year":"2023","unstructured":"Fang Y, Pan X, Shen H-B (2023) De novo drug design by iterative multiobjective deep reinforcement learning with graph-based molecular quality assessment. Bioinformatics 39(4):btad157","journal-title":"Bioinformatics"},{"key":"735_CR78","doi-asserted-by":"publisher","first-page":"40265","DOI":"10.1016\/j.heliyon.2024.e40265","volume":"10","author":"S Hashemi","year":"2024","unstructured":"Hashemi S et al (2024) Therapeutic peptide development revolutionized: harnessing the power of artificial intelligence for drug discovery. Heliyon. 10:40265","journal-title":"Heliyon."},{"key":"735_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01147","volume":"9","author":"X Huo","year":"2019","unstructured":"Huo X et al (2019) Clinical and expression significance of AKT1 by co-expression network analysis in endometrial cancer. Front Oncol 9:1147","journal-title":"Front Oncol"},{"key":"735_CR80","first-page":"1","volume":"21","author":"T Shimoi","year":"2021","unstructured":"Shimoi T et al (2021) Hotspot mutation profiles of AKT1 in Asian women with breast and endometrial cancers. Cancers 21:1\u20137","journal-title":"Cancers"},{"key":"735_CR81","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.canlet.2018.10.043","volume":"442","author":"EE Bonacquisti","year":"2019","unstructured":"Bonacquisti EE, Nguyen JJCL (2019) Connexin 43 (Cx43) in cancer: implications for therapeutic approaches via gap junctions. Cancer Lett 442:439\u2013444","journal-title":"Cancer Lett"},{"key":"735_CR82","first-page":"1800398","volume":"3","author":"A Morel","year":"2019","unstructured":"Morel A et al (2019) De Novo ESR1 hotspot mutation in a patient with endometrial cancer treated with an aromatase inhibitor. JCO Precis Oncol 3:1800398","journal-title":"JCO Precis Oncol"},{"issue":"3","key":"735_CR83","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1007\/s12010-023-04608-5","volume":"196","author":"PK Poleboyina","year":"2024","unstructured":"Poleboyina PK et al (2024) Virtual screening, molecular docking, and dynamic simulations revealed TGF-\u03b21 potential inhibitors to curtail cervical cancer progression. Appl Biochem Biotechnol 196(3):1316\u20131349","journal-title":"Appl Biochem Biotechnol"},{"issue":"4","key":"735_CR84","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.7314\/APJCP.2016.17.4.2291","volume":"17","author":"K Patidar","year":"2016","unstructured":"Patidar K et al (2016) Virtual screening approaches in identification of bioactive compounds Akin to delphinidin as potential HER2 inhibitors for the treatment of breast cancer. Asian Pac J Cancer Prev 17(4):2291\u20132295","journal-title":"Asian Pac J Cancer Prev"},{"issue":"5","key":"735_CR85","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15051414","volume":"15","author":"R Ouyang","year":"2023","unstructured":"Ouyang R et al (2023) Virtual screening-based study of novel anti-cancer drugs targeting G-Quadruplex. Pharmaceutics 15(5):1414","journal-title":"Pharmaceutics"},{"issue":"13","key":"735_CR86","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27134098","volume":"27","author":"M Aziz","year":"2022","unstructured":"Aziz M et al (2022) Deep learning and structure-based virtual screening for drug discovery against NEK7: a novel target for the treatment of cancer. Molecules 27(13):4098","journal-title":"Molecules"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00735-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-025-00735-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00735-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T20:02:00Z","timestamp":1768248120000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-025-00735-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":86,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["735"],"URL":"https:\/\/doi.org\/10.1007\/s10822-025-00735-9","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"25 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"47"}}